I GOT ENDO : Advanced Technologies for Uterine Health and Endometriosis

I GOT ENDO is a biotech company at the intersection of MedTech and DeepTech, focusing on delivering cutting-edge solutions, including bioquantum technologies, for individuals with uterine health conditions such as endometriosis. This all-in-one medical device is designed to offer accurate screening and diagnosis outside of traditional lab settings, empowering people with or without symptoms of the disease.

Key Features of I GOT ENDO

Bioquantum Technology for Endometriosis

I GOT ENDO utilizes bioquantum technology to develop a medical ecosystem that facilitates the early detection and precise diagnosis of endometriosis, addressing a critical need in healthcare for those with uterine conditions. The device's non-invasive approach enables users to obtain results without the need for a lab, offering an accessible option for uterine health management.

• Innovative Approach: Combining MedTech and DeepTech for a comprehensive, non-laboratory diagnosis.
• Targeted for Uterine Health: Specifically designed for individuals affected by endometriosis, with or without symptoms.

A Comprehensive Endometriosis Management Ecosystem

The all-in-one medical device developed by I GOT ENDO aims to improve the quality of life for those affected by endometriosis by providing a holistic solution for diagnosis and disease management. The company is deeply committed to human well-being, research, and innovation in healthcare, working to create accessible tools that simplify the process of managing this complex condition.

• Early Detection: Provides users with a convenient way to screen for endometriosis early.
• Accessible: Delivers an easy-to-use device that removes the need for laboratory involvement.

Part of the FemTech Movement

I GOT ENDO has been highlighted in the FemTech France Barometer, in collaboration with Wavestone, showcasing the company's role within the rapidly growing FemTech industry in France. With over 140 FemTech startups, France ranks as the third-largest FemTech market globally, behind the USA and the UK.

• Key Insights: 94% of FemTech startups in France are founded by women.
• Industry Recognition: I GOT ENDO is recognized as a key player in the FemTech landscape in France, supporting the health needs of people with uterine conditions.

I GOT ENDO is committed to advancing research and technology to improve healthcare for individuals with endometriosis and to contribute to the global FemTech movement.